A Study to Test How BI 764532 is Taken up by Tumours in People With Small-cell Lung Cancer or Neuroendocrine Cancer
- Conditions
- Interventions
- First Posted Date
- 2023-07-27
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 12
- Registration Number
- NCT05963867
- Locations
- 🇳🇱
Amsterdam UMC Locatie VUMC, Amsterdam, Netherlands
Oxygen Therapy Use in Patients With Fibrotic Interstitial Lung Disease
- Conditions
- First Posted Date
- 2023-07-24
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 114921
- Registration Number
- NCT05957198
- Locations
- 🇺🇸
Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, United States
A Study in Healthy Men to Test How Different Doses of BI 3000202 Are Tolerated and How Food Influences the Amount of BI 3000202 in the Blood
- First Posted Date
- 2023-07-14
- Last Posted Date
- 2023-11-30
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 68
- Registration Number
- NCT05945888
- Locations
- 🇩🇪
Humanpharmakologisches Zentrum Biberach, Biberach, Germany
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
- First Posted Date
- 2023-07-07
- Last Posted Date
- 2024-02-20
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 29
- Registration Number
- NCT05934942
- Locations
- 🇩🇪
CRS Clinical Research Services Berlin GmbH, Berlin, Germany
A Study in Healthy Men to Test How Well Different Doses of BI 1839100 Are Tolerated (1490-0003)
- First Posted Date
- 2023-07-07
- Last Posted Date
- 2023-11-08
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 24
- Registration Number
- NCT05934955
- Locations
- 🇯🇵
SOUSEIKAI Sumida Hospital, Tokyo, Sumida-ku, Japan
A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in the Brain That is Positive for DLL3
- First Posted Date
- 2023-06-23
- Last Posted Date
- 2024-12-11
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 20
- Registration Number
- NCT05916313
- Locations
- 🇳🇱
Erasmus Medisch Centrum-ROTTERDAM-50697, Rotterdam, Netherlands
🇺🇸University of California Irvine, Orange, California, United States
🇩🇪Universitätsklinikum Frankfurt, Frankfurt am Main, Germany
Natural History of Netherton Syndrome
- Conditions
- First Posted Date
- 2023-06-15
- Last Posted Date
- 2024-12-17
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 100
- Registration Number
- NCT05902663
- Locations
- 🇮🇹
Istituto Dermopatico Dell'Immacolata - IDI - IRCCS, Roma, Italy
🇺🇸Mission Dermatology Center, Rancho Santa Margarita, California, United States
A Study in Women With Overweight or Obesity to Test Whether Different Doses of BI 456906 Influence the Amount of a Contraceptive in the Blood
- First Posted Date
- 2023-06-09
- Last Posted Date
- 2024-12-11
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 24
- Registration Number
- NCT05896384
- Locations
- 🇩🇪
Charité Research Organisation GmbH, Berlin, Germany
Patients With Geographic Atrophy and Their Patient Journey in the United States (US)
- Conditions
- First Posted Date
- 2023-06-06
- Last Posted Date
- 2024-02-09
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 68563
- Registration Number
- NCT05891275
- Locations
- 🇺🇸
CorEvitas HQ, Waltham, Massachusetts, United States
Non-interventional Study (NIS) on Sodium-glucose Co-transporter-2 Inhibitors (SGLT2i) Use in France
- Conditions
- Interventions
- First Posted Date
- 2023-05-31
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 547150
- Registration Number
- NCT05882071
- Locations
- 🇫🇷
Boehringer Ingelheim, Paris, France